On June 29, 2026, one of the most consequential hearings in the history of US cannabis policy, the crucial DEA
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market. Today (June
Cannabis stocks have once again been sent flying in the wake of the latest hint of progress on cannabis rescheduling
President Donald Trump’s executive order directing federal agencies to move cannabis from Schedule I to Schedule III of the Controlled
The UK’s health service is fighting to keep its head above water, yet with a record-breaking winter flu pandemic sweeping
Why Reading Research Matters The volume of cannabis research has never been higher, but not all studies are created equal.
First published on Cannabis Health Medical cannabis patients made history in London with a first-of-its-kind, patient-led education event focused on
Sorting Evidence from Anecdote As global cannabis research accelerates, the number of published studies has never been higher, but not
Accredited Medical Cannabis Symposium Could ‘Benefit Thousands of Patients’, Says Expert
The European medical cannabis industry is continuing to mature, seeing companies focused on science-based research push the boundaries of our
Since Germany’s Cannabis Act (CanG) came into force on 1 April 2024, much has changed regarding what was once the
When Germany introduced the Recreational Cannabis Act (KCanG), it not only legalised home cultivation and consumption for adults but also
This opinion piece was written by Calvin Rasode, Vice President, Marketing, Brains Bioceutical When Donald Trump tweets, the world pays
At its core, Standard Seed AI’s technology has the power to scientifically validate the entourage effect, streamline drug discovery, and drastically reduce the time and cost of bringing cannabis-based medicines to market.
Cannabis-related scientific research is woefully undersupported in the US, with less than half of the states which have legalized cannabis in some form offering provisions for research.
The US Department of Justice (DOJ) has determined that protections preventing the removal of Administrative Law Judges (ALJs) are unconstitutional and will no longer defend them in court, a move that could have significant implications for cannabis research.
The largest bipartisan coalition of cannabis advocacy, industry, and grassroots organizations, is set to descend on the US capital for
A cannabinoid drug company has opted to undertake its trials in America due to the complexities of the UK’s licensing regime.
We won’t spam you
